UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File number
0-12515
(Check One)
[ ] Form 10-K and Form 10-KSB
[ ] Form 20-F
[ ] Form 11-K
[X] Form 10-Q and Form 10-QSB
[ ] Form N-SAR
For Period Ended: February 28, 1998.
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ________________.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
Part I -- Registrant Information.
Biomet, Inc.
(Full name of registrant)
Airport Industrial Park, P.O. Box 587
(Address of principal executive office)
Warsaw, Indiana 46581-0587
(City, State and Zip Code)
Part II -- Rules 12b-25 (b) and (c).
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense;
(b) The subject annual report, semi-annual report, transition
report of Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable. (Not applicable)
Part III -- Narrative.
Biomet, Inc. and Merck KGaA, Darmstadt, Germany, signed the
Biomet/Merck joint venture agreement during the last quarter.
Due to the complex accounting of this transaction and the
inability to obtain timely financial information from all of the
additional European subsidiaries, it is not possible to file the
Form 10-Q by the prescribed due date.
Part IV -- Other Information.
(1) Name and telephone number of person to contact in regard
to this notification; Gregory D. Hartman 219-267-6639
(2) Have all other periodic reports required under section 13
or 15(d) of the Securities Exchange Act of 1934 or section 30 of
the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was
required to file such report(s) been filed? If the answer is
no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included
in the subject report or portion thereof? [ ] Yes [X] No
BIOMET, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
DATE: 4/14/98 BY: /s/ GREGORY D. HARTMAN
Gregory D. Hartman
Vice President - Finance
(Principal Financial Officer)
